ISRG insider buying and SEC filings, explained
Intuitive Surgical Inc. · CIK 1035267
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$69.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 29–30, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 124 shares between Oct 29 and Oct 30 at about $450.77 ($56K), marked as a 10b5-1 plan trade. Holdings down 21% to 457 shares. | SEC filing Filed Nov 2, 2026, 3:11 PM ET |
| Oct 30, 2026 | Planned (10b5-1) | Fredrik Widman (VP Corporate Controller) sold 5,448 shares at about $436.06 ($2.4M), marked as a 10b5-1 plan trade. Holdings down 84% to 1,026 shares. | SEC filing Filed Nov 2, 2026, 2:53 PM ET |
| Oct 26–28, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 183 shares between Oct 26 and Oct 28 at about $448.33 ($82K), marked as a 10b5-1 plan trade. Holdings down 24% to 581 shares. | SEC filing Filed Oct 28, 2026, 6:01 PM ET |
| Oct 23, 2026 | Planned (10b5-1) | Craig H. Barratt (Director) sold 1,150 shares at $443.80 ($510K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 26, 2026, 3:20 PM ET |
| Oct 23, 2026 | Planned (10b5-1) | Fredrik Widman (VP Corporate Controller) sold 4,047 shares at about $453.21 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 80% to 1,026 shares. | SEC filing Filed Oct 26, 2026, 3:02 PM ET |
| Oct 23, 2026 | Planned (10b5-1) | Patricia L. Wadors (SVP Chief Human Resources Offi) sold 1,078 shares at $443.80 ($478K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Oct 26, 2026, 2:54 PM ET |
| Oct 23, 2026 | Planned (10b5-1) | Gary S. Guthart (Director) sold 20,095 shares indirectly (by trust) at about $451.61 ($9.1M), marked as a 10b5-1 plan trade. Holdings by trust down 2% to 1,204,530 shares. | SEC filing Filed Oct 26, 2026, 2:32 PM ET |
| Sep 15, 2026 | Planned (10b5-1) | Fredrik Widman (VP Corporate Controller) sold 1,089 shares at $374.44 ($408K), marked as a 10b5-1 plan trade. Holdings down 51% to 1,026 shares. | SEC filing Filed Sep 16, 2026 |
| Sep 10–11, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 48 shares between Sep 10 and Sep 11 at about $357.10 ($17K), marked as a 10b5-1 plan trade. Holdings down 6% to 764 shares. | SEC filing Filed Sep 11, 2026 |
| Sep 8–9, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 69 shares between Sep 8 and Sep 9 at about $357.55 ($25K), marked as a 10b5-1 plan trade. Holdings down 8% to 812 shares. | SEC filing Filed Sep 9, 2026 |
| Aug 20–21, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 154 shares between Aug 20 and Aug 21 at about $385.97 ($59K), marked as a 10b5-1 plan trade. Holdings down 15% to 881 shares. | SEC filing Filed Aug 21, 2026 |
| Aug 17–19, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 231 shares between Aug 17 and Aug 19 at about $392.98 ($91K), marked as a 10b5-1 plan trade. Holdings down 18% to 1,035 shares. | SEC filing Filed Aug 19, 2026 |
| Aug 11, 2026 | Planned (10b5-1) | Gary S. Guthart (Director) sold 10,000 shares indirectly (by trust) at $400.00 ($4.0M), marked as a 10b5-1 plan trade. Holdings by trust down 1% to 1,245,679 shares. | SEC filing Filed Aug 12, 2026 |
| Aug 10–11, 2026 | Planned (10b5-1) | Amy L Ladd (Director) sold 472 shares between Aug 10 and Aug 11 at about $381.15 ($180K), marked as a 10b5-1 plan trade. Holdings down 73% to 179 shares. | SEC filing Filed Aug 11, 2026 |
| Aug 10, 2026 | Planned (10b5-1) | Gary Loeb (EVP & Chief Legal and Complian) sold 400 shares at $379.00 ($152K), marked as a 10b5-1 plan trade. Holdings down 7% to 5,320 shares. | SEC filing Filed Aug 10, 2026 |
| Jul 30–31, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 56 shares between Jul 30 and Jul 31 at about $348.92 ($20K), marked as a 10b5-1 plan trade. Holdings down 4% to 1,266 shares. | SEC filing Filed Jul 31, 2026 |
| Jul 27–29, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 84 shares between Jul 27 and Jul 29 at about $356.60 ($30K), marked as a 10b5-1 plan trade. Holdings down 6% to 1,322 shares. | SEC filing Filed Jul 29, 2026 |
| Jun 11–12, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 48 shares between Jun 11 and Jun 12 at about $413.19 ($20K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,406 shares. | SEC filing Filed Jun 12, 2026 |
| Jun 10, 2026 | Planned (10b5-1) | Gary Loeb (EVP & Chief Legal and Complian) sold 400 shares at $424.14 ($170K), marked as a 10b5-1 plan trade. Holdings down 7% to 5,720 shares. | SEC filing Filed Jun 10, 2026 |
| Jun 8–10, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 69 shares between Jun 8 and Jun 10 at about $421.80 ($29K), marked as a 10b5-1 plan trade. Holdings down 5% to 1,454 shares. | SEC filing Filed Jun 10, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Iman Jeddi (SVP & GM da Vinci Platforms &) sold 5,625 shares at $420.55 ($2.4M), marked as a 10b5-1 plan trade. Holdings down 47% to 6,463 shares. | SEC filing Filed Jun 2, 2026 |
| May 21–22, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 36 shares between May 21 and May 22 at about $442.92 ($16K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,523 shares. | SEC filing Filed May 22, 2026 |
| May 18–20, 2026 | Planned (10b5-1) | Mark Brosius (EVP & Chief Mfg and Supply Cha) sold 54 shares between May 18 and May 20 at about $434.52 ($23K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,559 shares. | SEC filing Filed May 20, 2026 |
| May 11, 2026 | Planned (10b5-1) | Gary Loeb (EVP & Chief Legal and Complian) sold 400 shares at $446.95 ($179K), marked as a 10b5-1 plan trade. Holdings down 6% to 6,120 shares. | SEC filing Filed May 11, 2026 |
| Apr 28–29, 2026 | Planned (10b5-1) | Amy L Ladd (Director) sold 619 shares between Apr 28 and Apr 29 at about $471.55 ($292K), marked as a 10b5-1 plan trade. Holdings down 84% to 120 shares. | SEC filing Filed Apr 29, 2026 |
| Mar 10, 2026 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 105 shares at $493.95 ($52K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 6–9, 2026 | Planned (10b5-1) | Mark Brosius (SVP & Chief Mfg and Supply Cha) sold 1,293 shares between Mar 6 and Mar 9 at about $487.61 ($630K), marked as a 10b5-1 plan trade. Holdings down 44% to 1,613 shares. | SEC filing Filed Mar 10, 2026 |
| Mar 3–5, 2026 | Planned (10b5-1) | Mark Brosius (SVP & Chief Mfg and Supply Cha) sold 3,658 shares between Mar 3 and Mar 5 at about $496.19 ($1.8M), marked as a 10b5-1 plan trade. Holdings down 56% to 2,906 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 2–3, 2026 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 4,853 shares indirectly (by trust) between Mar 2 and Mar 3 at about $487.32 ($2.4M), marked as a 10b5-1 plan trade. Holdings by trust down 92% to 409 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 27–Mar 3, 2026 | Planned (10b5-1) | Fredrik Widman (VP Corporate Controller) sold 367 shares between Feb 27 and Mar 3 at about $495.68 ($182K), marked as a 10b5-1 plan trade. Holdings down 26% to 1,026 shares. | SEC filing Filed Mar 3, 2026 |
| Feb 27, 2026 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 2,345 shares indirectly (by trust) at $499.71 ($1.2M), marked as a 10b5-1 plan trade. Holdings by trust down 85% to 409 shares. | SEC filing Filed Mar 2, 2026 |
| Feb 27, 2026 | Planned (10b5-1) | Patricia L. Wadors (SVP Chief Human Resources Offi) sold 220 shares at $499.71 ($110K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Feb 27, 2026 |
| Feb 11, 2026 | Planned (10b5-1) | Fredrik Widman (VP Corporate Controller) sold 133 shares at $494.96 ($66K), marked as a 10b5-1 plan trade. Holdings down 17% to 660 shares. | SEC filing Filed Feb 11, 2026 |
| Feb 10–11, 2026 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 526 shares indirectly (by trust) between Feb 10 and Feb 11 at about $494.90 ($260K), marked as a 10b5-1 plan trade. Holdings by trust down 56% to 409 shares. | SEC filing Filed Feb 11, 2026 |
| Jan 29, 2026 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 126 shares at $520.02 ($66K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 30, 2026 |
| Jan 27, 2026 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 230 shares at $532.61 ($123K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 28, 2026 |
| Jan 27, 2026 | Planned (10b5-1) | Gary S. Guthart (Director) sold 27,300 shares directly and indirectly (by trust) at about $530.25 ($14.5M), marked as a 10b5-1 plan trade. Direct holdings down 87% to 3,694 shares. | SEC filing Filed Jan 28, 2026 |
| Dec 15, 2025 | Planned (10b5-1) | Mark Brosius (Officer) sold 464 shares at $548.49 ($254K), marked as a 10b5-1 plan trade. Holdings down 78% to 131 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 12–15, 2025 | Planned (10b5-1) Amended filing | Mark Brosius (Officer) sold 776 shares between Dec 12, 2025 and Dec 15, 2025 at about $548.04 ($425K), marked as a 10b5-1 plan trade. Holdings down 64% to 443 shares. This amends a filing from Dec 15, 2025. | SEC filing Filed Dec 17, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 104 shares at $559.90 ($58K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 125 shares at $568.99 ($71K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Gary S. Guthart (Chair and Director) sold 22,806 shares at about $570.89 ($13.0M), marked as a 10b5-1 plan trade. Holdings down 89% to 2,694 shares. | SEC filing Filed Dec 2, 2025 |
| Nov 12, 2025 | Planned (10b5-1) | Henry L Charlton (EVP & Chief Commercial and Mkt) sold 13,731 shares at $580.00 ($8.0M), marked as a 10b5-1 plan trade. Holdings down 82% to 3,056 shares. | SEC filing Filed Nov 13, 2025 |
| Nov 12, 2025 | Planned (10b5-1) | Craig H. Barratt (Director) sold 750 shares at $580.00 ($435K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 13, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Brian Edward Miller (EVP & Chief Digital Officer) sold 3,500 shares at $575.00 ($2.0M), marked as a 10b5-1 plan trade. Holdings down 38% to 5,758 shares. | SEC filing Filed Nov 12, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Myriam Curet (EVP & Chief Medical Officer) sold 105 shares at $560.00 ($59K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Nov 12, 2025 |
| Nov 5, 2025 | Planned (10b5-1) | Fredrik Widman (VP Corporate Controller) sold 2,067 shares at $550.00 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 81% to 473 shares. | SEC filing Filed Nov 6, 2025 |
69 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 2, 2026, 4:17 PM ET 8-K | Executive or director change (Item 5.02) Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ISRG in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.